Cocrystal Pharma, Inc. SEC filings COCP
Cocrystal Pharma, Inc. has 672 filings in SEC EDGAR's recent list, going back to Sep 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Apr 23, 2026 | — |
| 424B3 | Prospectus | Sep 29, 2025 | — |
| S-1 | Registration statement | Sep 19, 2025 | — |
| 424B5 | Prospectus supplement | Sep 15, 2025 | — |
| 424B3 | Prospectus | Sep 12, 2025 | — |
| 424B5 | Prospectus supplement | Jun 15, 2023 | — |
| S-3/A | Filing | May 24, 2023 | — |
| S-3 | Shelf registration | May 12, 2023 | — |
| 424B5 | Prospectus supplement | May 5, 2021 | — |
| 424B5 | Prospectus supplement | Aug 27, 2020 | — |
| 424B5 | Prospectus supplement | Aug 26, 2020 | — |
| 424B5 | Prospectus supplement | Jul 1, 2020 | — |
| S-3/A | Filing | May 4, 2020 | — |
| S-3 | Shelf registration | Apr 17, 2020 | — |
| 424B5 | Prospectus supplement | Mar 10, 2020 | — |
| 424B5 | Prospectus supplement | Feb 28, 2020 | — |
| 424B5 | Prospectus supplement | Jan 31, 2020 | — |
| 424B5 | Prospectus supplement | Jan 31, 2020 | — |
| 424B5 | Prospectus supplement | Oct 31, 2019 | — |
| 424B5 | Prospectus supplement | Oct 31, 2019 | — |
| 424B5 | Prospectus supplement | Oct 30, 2019 | — |
| S-3/A | Filing | May 15, 2019 | — |
| S-3 | Shelf registration | Apr 25, 2019 | — |
| 424B5 | Prospectus supplement | Jul 20, 2018 | — |
| S-8 | Employee stock plan registration | May 11, 2018 | — |
| 424B5 | Prospectus supplement | May 3, 2018 | — |
| 424B5 | Prospectus supplement | Apr 3, 2018 | — |
| S-3/A | Filing | Oct 5, 2017 | — |
| S-3 | Shelf registration | Sep 26, 2017 | — |
| S-3 | Shelf registration | Aug 14, 2015 | — |
| S-8 | Employee stock plan registration | Jan 2, 2014 | — |
| 424B7 | Filing | Feb 26, 2013 | — |
| S-1/A | Amended registration statement | Feb 13, 2013 | — |
| S-1/A | Amended registration statement | Feb 8, 2013 | — |
| S-1/A | Amended registration statement | Jan 31, 2013 | — |
| S-1/A | Amended registration statement | Jan 14, 2013 | — |
| S-1/A | Amended registration statement | Nov 29, 2012 | — |
| S-1/A | Amended registration statement | Sep 28, 2012 | — |
| S-1/A | Amended registration statement | Jul 2, 2012 | — |
| S-1/A | Amended registration statement | Dec 19, 2011 | — |
| S-1 | Registration statement | Sep 21, 2011 | — |
| POS AM | Isri pos-am 07/14/10 | Jul 14, 2010 | — |
| 424B3 | Prospectus | Oct 9, 2007 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COCP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bothell, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1412486
- Former names
- BIOZONE PHARMACEUTICALS, INC. (until Mar 25, 2014); International Surf Resorts, Inc. (until Mar 4, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.